Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Clinical features of pseudocirrhosis in metastatic breast cancer.

Oliai C, Douek ML, Rhoane C, Bhutada A, Ge PS, Runyon BA, Wang X, Hurvitz SA.

Breast Cancer Res Treat. 2019 Jun 7. doi: 10.1007/s10549-019-05311-y. [Epub ahead of print]

PMID:
31175499
2.

Is sentinel node biopsy necessary in the radiologically negative axilla in breast cancer?

Jozsa F, Ahmed M, Baker R, Douek M.

Breast Cancer Res Treat. 2019 May 31. doi: 10.1007/s10549-019-05299-5. [Epub ahead of print]

PMID:
31152326
3.

Components of Radiologic Progressive Disease Defined by RECIST 1.1 in Patients with Metastatic Clear Cell Renal Cell Carcinoma.

Coy HJ, Douek ML, Ruchalski K, Kim HJ, Gutierrez A, Patel M, Sai V, Margolis DJA, Kaplan A, Brown M, Goldin J, Raman SS.

Radiology. 2019 May 14:182922. doi: 10.1148/radiol.2019182922. [Epub ahead of print]

PMID:
31084479
4.

The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 study.

O'Connell RL, Rattay T, Dave RV, Trickey A, Skillman J, Barnes NLP, Gardiner M, Harnett A, Potter S, Holcombe C; iBRA-2 Steering Group; Breast Reconstruction Research Collaborative.

Br J Cancer. 2019 Apr;120(9):883-895. doi: 10.1038/s41416-019-0438-1. Epub 2019 Mar 29.

PMID:
30923359
5.

Deep learning and radiomics: the utility of Google TensorFlowâ„¢ Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT.

Coy H, Hsieh K, Wu W, Nagarajan MB, Young JR, Douek ML, Brown MS, Scalzo F, Raman SS.

Abdom Radiol (NY). 2019 Jun;44(6):2009-2020. doi: 10.1007/s00261-019-01929-0.

PMID:
30778739
6.

Opportunities and priorities for breast surgical research.

Cutress RI, McIntosh SA, Potter S, Goyal A, Kirwan CC, Harvey J, Francis A, Carmichael AR, Vidya R, Vaidya JS, Fairbrother P, Benson JR, Reed MWR; Association of Breast Surgery Surgical Gap Analysis Working Group.

Lancet Oncol. 2018 Oct;19(10):e521-e533. doi: 10.1016/S1470-2045(18)30511-4. Epub 2018 Oct 1. Review.

PMID:
30303126
7.

Association of the Gross Appearance of Intratumoral Vascularity at MDCT With the Carbonic Anhydrase IX Score in Clear Cell Renal Cell Carcinoma.

Young JR, Coy H, Kim HJ, Douek M, Sisk A, Pantuck AJ, Raman SS.

AJR Am J Roentgenol. 2018 Dec;211(6):1254-1258. doi: 10.2214/AJR.18.19725. Epub 2018 Oct 9.

PMID:
30300009
8.

Association of qualitative and quantitative imaging features on multiphasic multidetector CT with tumor grade in clear cell renal cell carcinoma.

Coy H, Young JR, Douek ML, Pantuck A, Brown MS, Sayre J, Raman SS.

Abdom Radiol (NY). 2019 Jan;44(1):180-189. doi: 10.1007/s00261-018-1688-8.

PMID:
29987358
9.

Clear cell renal cell carcinoma: identifying PTEN expression on multiphasic MDCT.

Young JR, Coy H, Kim HJ, Douek M, Sisk A, Pantuck AJ, Raman SS.

Abdom Radiol (NY). 2018 Dec;43(12):3410-3417. doi: 10.1007/s00261-018-1672-3.

PMID:
29946925
10.

Combined use of fluorescence with a magnetic tracer and dilution effect upon sentinel node localization in a murine model.

Kuwahata A, Ahmed M, Saeki K, Chikaki S, Kaneko M, Qiu W, Xin Z, Yamaguchi S, Kaneko A, Douek M, Kusakabe M, Sekino M.

Int J Nanomedicine. 2018 Apr 19;13:2427-2433. doi: 10.2147/IJN.S153163. eCollection 2018.

11.

Gene Expression Classifier vs Targeted Next-Generation Sequencing in the Management of Indeterminate Thyroid Nodules.

Livhits MJ, Kuo EJ, Leung AM, Rao J, Levin M, Douek ML, Beckett KR, Zanocco KA, Cheung DS, Gofnung YA, Smooke-Praw S, Yeh MW.

J Clin Endocrinol Metab. 2018 Jun 1;103(6):2261-2268. doi: 10.1210/jc.2017-02754.

PMID:
29590358
12.

Utility of multiphasic multidetector computed tomography in discriminating between clear cell renal cell carcinomas with high and low carbonic anhydrase-IX expression.

Young JR, Coy H, Kim HJ, Douek M, Sisk A, Belldegrun A, Pantuck AJ, Raman SS.

Abdom Radiol (NY). 2018 Oct;43(10):2734-2742. doi: 10.1007/s00261-018-1546-8.

PMID:
29520426
13.

Novel techniques for intraoperative assessment of margin involvement.

Dumitru D, Douek M, Benson JR.

Ecancermedicalscience. 2018 Jan 10;12:795. doi: 10.3332/ecancer.2018.795. eCollection 2018. Review.

14.

Update on intraoperative radiotherapy: new challenges and issues.

Esposito E, Douek M.

Ecancermedicalscience. 2018 Jan 10;12:793. doi: 10.3332/ecancer.2018.793. eCollection 2018. Review.

15.

Ablative techniques for the treatment of benign and malignant breast tumours.

Peek MCL, Douek M.

J Ther Ultrasound. 2017 Jul 3;5:18. doi: 10.1186/s40349-017-0097-8. eCollection 2017. Review.

16.

How can nanoparticles be used in sentinel node detection?

Ahmed M, Peek MC, Douek M.

Nanomedicine (Lond). 2017 Jul;12(13):1525-1527. doi: 10.2217/nnm-2017-0137. Epub 2017 Jun 16. No abstract available.

17.

Clear Cell Renal Cell Carcinoma: Identifying the Loss of the Y Chromosome on Multiphasic MDCT.

Young JR, Coy H, Douek M, Lo P, Sayre J, Pantuck AJ, Raman SS.

AJR Am J Roentgenol. 2017 Aug;209(2):333-338. doi: 10.2214/AJR.16.17010. Epub 2017 May 15.

PMID:
28504543
19.

Type 1 papillary renal cell carcinoma: differentiation from Type 2 papillary RCC on multiphasic MDCT.

Young JR, Coy H, Douek M, Lo P, Sayre J, Pantuck AJ, Raman SS.

Abdom Radiol (NY). 2017 Jul;42(7):1911-1918. doi: 10.1007/s00261-017-1091-x.

PMID:
28265706
20.

Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.

Young JR, Coy H, Kim HJ, Douek M, Lo P, Pantuck AJ, Raman SS.

AJR Am J Roentgenol. 2017 Apr;208(4):812-819. doi: 10.2214/AJR.16.17152. Epub 2017 Jan 26.

PMID:
28125273

Supplemental Content

Loading ...
Support Center